Systemic lupus erythematosus (SLE) is a devastating autoimmune disease that can result in
substantial morbidity and mortality. Diagnosis and treatment of SLE are clinical challenges …

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by
antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by …

Objective. Growing evidence suggests increasing frequencies of autoimmunity and certain
autoimmune diseases, but findings are limited by the lack of systematic data and evolving …

Antinuclear antibodies (ANAs) are valuable laboratory markers to screen for and support the
diagnosis of various rheumatic diseases (known as ANA-associated rheumatic diseases) …

Disease-specific autoantibodies are considered the most important biomarkers for systemic
sclerosis (SSc), due to their ability to stratify patients with different severity and prognosis …

Idiopathic inflammatory myopathies (IIM) are a heterogenous family of diseases that can
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …

Systemic lupus erythematosus (SLE) is characterized by immune system dysfunction and is
clinically heterogeneous, exhibiting renal, dermatological, neuropsychiatric, and …

Deep learning has emerged as the leading method in machine learning, spawning a rapidly
growing field of academic research and commercial applications across medicine. Deep …

The incidence of autoimmune diseases is increasing. Antinuclear antibody (ANA) testing is a
critical tool for their diagnosis. However, ANA prevalence in healthy persons has increased …

Systemic sclerosis and autoimmune myositis are both associated with decreased quality of
life and increased mortality. Their prognosis and management largely depend on the …